Stem Cell Niches in Glioblastoma: A Neuropathological View
Open Access
- 1 January 2014
- journal article
- retracted article
- Published by Wiley in BioMed Research International
- Vol. 2014, 1-7
Abstract
Glioblastoma (GBM) stem cells (GSCs), responsible for tumor growth, recurrence, and resistance to therapies, are considered the real therapeutic target, if they had no molecular mechanisms of resistance, in comparison with the mass of more differentiated cells which are insensitive to therapies just because of being differentiated and nonproliferating. GSCs occur in tumor niches where both stemness status and angiogenesis are conditioned by the microenvironment. In both perivascular and perinecrotic niches, hypoxia plays a fundamental role. Fifteen glioblastomas have been studied by immunohistochemistry and immunofluorescence for stemness and differentiation antigens. It has been found that circumscribed necroses develop inside hyperproliferating areas that are characterized by high expression of stemness antigens. Necrosis developed inside them because of the imbalance between the proliferation of tumor cells and endothelial cells; it reduces the number of GSCs to a thin ring around the former hyperproliferating area. The perinecrotic GSCs are nothing else that the survivors remnants of those populating hyperproliferating areas. In the tumor, GSCs coincide with malignant areas so that the need to detect where they are located is not so urgent.Keywords
Funding Information
- Compagnia di San Paolo (4011 SD/cv 2011-0438)
This publication has 53 references indexed in Scilit:
- Mechanisms of Glioma-Associated NeovascularizationThe American Journal of Pathology, 2012
- Fluorescence-guided surgical sampling of glioblastoma identifies phenotypically distinct tumour-initiating cell populations in the tumour mass and marginBritish Journal of Cancer, 2012
- REST Controls Self-Renewal and Tumorigenic Competence of Human Glioblastoma CellsPLOS ONE, 2012
- The transcriptional coactivator TAZ regulates mesenchymal differentiation in malignant gliomaGenes & Development, 2011
- Asymmetry-Defective Oligodendrocyte Progenitors Are Glioma PrecursorsCancer Cell, 2011
- Mosaic Analysis with Double Markers Reveals Tumor Cell of Origin in GliomaCell, 2011
- Non-Stem Cell Origin for OligodendrogliomaCancer Cell, 2010
- Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1Cancer Cell, 2010
- Combinations of genetic mutations in the adult neural stem cell compartment determine brain tumour phenotypesThe EMBO Journal, 2009
- Malignant Astrocytomas Originate from Neural Stem/Progenitor Cells in a Somatic Tumor Suppressor Mouse ModelCancer Cell, 2009